Patents Assigned to TetraLogic Pharmaceuticals Corp.
  • SMAC Mimetic
    Publication number: 20140073579
    Abstract: A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
    Type: Application
    Filed: November 8, 2013
    Publication date: March 13, 2014
    Applicant: TETRALOGIC PHARMACEUTICALS CORP.
    Inventors: Stephen M. Condon, Yijun DENG, Matthew G. LaPorte, Susan R. Rippin
  • SMAC mimetic
    Patent number: 8603816
    Abstract: A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: December 10, 2013
    Assignee: TetraLogic Pharmaceuticals Corp.
    Inventors: Stephen M. Condon, Yijun Deng, Matthew G. LaPorte, Susan R. Rippin
  • IAP inhibitors
    Patent number: 8415486
    Abstract: The present invention describes compounds, processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: April 9, 2013
    Assignee: TetraLogic Pharmaceuticals Corp.
    Inventors: Stephen M. Condon, Yijun Deng, Matthew D. Alexander, Matthew G. Laporte
  • SMAC Mimetic
    Publication number: 20130012564
    Abstract: A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 10, 2013
    Applicant: TETRALOGIC PHARMACEUTICALS CORP.
    Inventors: Stephen M. CONDON, Yijun DENG, Matthew G. LaPorte, Susan R. Rippin
  • 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
    Patent number: 8283372
    Abstract: A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
    Type: Grant
    Filed: June 20, 2010
    Date of Patent: October 9, 2012
    Assignee: TetraLogic Pharmaceuticals Corp.
    Inventors: Stephen M. Condon, Yijun Deng, Matthew G. Laporte, Susan R. Rippin
  • IAP INHIBITORS
    Publication number: 20120135990
    Abstract: The present invention describes compounds, processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Application
    Filed: May 27, 2010
    Publication date: May 31, 2012
    Applicant: TETRALOGIC PHARMACEUTICALS CORP.
    Inventors: Stephen M. Condon, Yijun Deng, Matthew D. Alexander, Matthew G. Laporte
  • IAP INHIBITORS
    Publication number: 20120094917
    Abstract: The present invention describes compounds, processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Application
    Filed: May 25, 2010
    Publication date: April 19, 2012
    Applicant: TETRALOGIC PHARMACEUTICALS CORP
    Inventors: Stephen M. Condon, Yijun Deng, Matthew D. Alexander, Matthew G. Laporte
  • TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS
    Publication number: 20110008802
    Abstract: TNF? gene expression can be used as a biomarker of a cell's sensitivity to antagonists of inhibitor of apoptosis proteins (IAPs). Methods of the invention are useful for screening patients to identify those who could benefit from administration of an IAP antagonist to treat various malignant or benign tumors, benign proliferative diseases, or autoimmune diseases.
    Type: Application
    Filed: May 7, 2008
    Publication date: January 13, 2011
    Applicant: TETRALOGIC PHARMACEUTICALS CORP.
    Inventors: Alireza Alavi, Mark A. McKinlay, Srinivas K. Chunduru, John Silke, David Vaux, James Vince